Cargando…
Transcranial Photobiomodulation For The Management Of Depression: Current Perspectives
Major depressive disorder (MDD) is a prevalent condition associated with high rates of disability, as well as suicidal ideation and behavior. Current treatments for MDD have significant limitations in efficacy and side effect burden. FDA-approved devices for MDD are burdensome (due to repeated in-of...
Autores principales: | Askalsky, Paula, Iosifescu, Dan V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878920/ https://www.ncbi.nlm.nih.gov/pubmed/31819453 http://dx.doi.org/10.2147/NDT.S188906 |
Ejemplares similares
-
Protocol Report on the Transcranial Photobiomodulation for Alzheimer’s Disease (TRAP-AD) Study
por: Iosifescu, Dan V., et al.
Publicado: (2023) -
Transcranial Photobiomodulation to Improve Cognition in Gulf War Illness
por: Martin, Paula I., et al.
Publicado: (2021) -
Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives
por: Hamblin, Michael R
Publicado: (2019) -
Exploring the use of transcranial photobiomodulation in Parkinson's disease patients
por: Hamilton, Catherine, et al.
Publicado: (2018) -
Transcranial Photobiomodulation Therapy in the Cognitive Rehabilitation of Patients with Cranioencephalic Trauma
por: Carneiro, Ana Maria Costa, et al.
Publicado: (2019)